Comparison between International Gemmological IPO and Suraksha Diagnostic IPO.
International Gemmological IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Suraksha Diagnostic IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of International Gemmological IPO is up to ₹4,225.00 Cr whereas the issue size of the Suraksha Diagnostic IPO is up to ₹846.25 Cr. The final issue price of International Gemmological IPO is ₹417.00 per share and of Suraksha Diagnostic IPO is ₹441.00 per share.
| International Gemmological IPO | Suraksha Diagnostic IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹2 per share |
| Issue Price (Lower) | ₹397.00 per share | ₹420.00 per share |
| Issue Price (Upper) | ₹417.00 per share | ₹441.00 per share |
| Issue Price (Final) | ₹417.00 per share | ₹441.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹39.00 per share | |
| Market Lot Size | 35 shares | 34 shares |
| Fresh Issue Size | 3,53,76,651 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹1,475.13 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 6,59,47,242 shares | 1,91,89,330 shares |
| OFS Issue Size (Amount) | up to ₹2,749.87 Cr | up to ₹846.25 Cr |
| Issue Size Total | 10,13,23,893 shares | 1,91,89,330 shares |
| Issue Size Total (Amount) | up to ₹4,225.00 Cr | up to ₹846.25 Cr |
International Gemmological IPO opens on Dec 13, 2024, while Suraksha Diagnostic IPO opens on Nov 29, 2024. The closing date of International Gemmological IPO and Suraksha Diagnostic IPO is Dec 17, 2024, and Dec 03, 2024, respectively.
| International Gemmological IPO | Suraksha Diagnostic IPO | |
|---|---|---|
| Anchor Bid Date | Dec 12, 2024 | Nov 28, 2024 |
| Issue Open | Dec 13, 2024 | Nov 29, 2024 |
| Issue Close | Dec 17, 2024 | Dec 03, 2024 |
| Basis Of Allotment (Tentative) | Dec 18, 2024 | Dec 04, 2024 |
| Initiation of Refunds (Tentative) | Dec 19, 2024 | Dec 05, 2024 |
| Credit of Share (Tentative) | Dec 19, 2024 | Dec 05, 2024 |
| Listing date (Tentative) | Dec 20, 2024 | Dec 06, 2024 |
| Anchor Lockin End date 1 | Jan 16, 2025 | Jan 03, 2025 |
| Anchor Lockin End date 2 | Mar 17, 2025 | Mar 04, 2025 |
International Gemmological IPO P/E ratio is 50.98, as compared to Suraksha Diagnostic IPO P/E ratio of 99.31.
| International Gemmological IPO | Suraksha Diagnostic IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 61.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 76.55 | 48.78 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 50.98 | 99.31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹18020.85 Cr. | ₹2296.76 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 76.58% | 14.09% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 80.96% | 21.46% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.44 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 76.58% | 14.09% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the International Gemmological IPO Retail Individual Investors (RII) are offered 1,01,27,098 shares while in Suraksha Diagnostic IPO retail investors are offered 1,01,27,098 shares. Qualified Institutional Buyers (QIB) are offered 3,03,81,296 shares in International Gemmological IPO and 38,37,867 shares in Suraksha Diagnostic IPO.
| International Gemmological IPO | Suraksha Diagnostic IPO | |
|---|---|---|
| Anchor Investor Reservation | 4,55,71,942 shares | 57,56,797 shares |
| Market Maker Reservation | ||
| QIB | 3,03,81,296 shares | 38,37,867 shares |
| NII | 1,51,90,647 shares | 28,78,400 shares |
| RII | 1,01,27,098 shares | 67,16,266 shares |
| Employee | 52,910 shares | |
| Others | ||
| Total | 10,13,23,893 shares | 1,91,89,330 shares |
International Gemmological IPO subscribed 35.48x in total, whereas Suraksha Diagnostic IPO subscribed 1.27x.
| International Gemmological IPO | Suraksha Diagnostic IPO | |
|---|---|---|
| QIB (times) | 48.11x | 1.74x |
| NII (times) | 26.09x | 1.40x |
| Big NII (times) | 29.78x | 1.53x |
| Small NII (times) | 18.70x | 1.16x |
| RII (times) | 11.77x | 0.94x |
| Employee (times) | 21.79x | |
| Other (times) | ||
| Total (times) | 35.48x | 1.27x |
